Sands Capital Management
AGN

Sands Capital Management’s Allergan Inc AGN Stock Holding History

Sands Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-7,422,715
Closed -$671M – 45
2013
Q3 		$671M Sell
7,422,715
-2,176,249
-23% -$195M 1.87% 23
2013
Q2 		$809M Buy
+9,598,964
New +$996M 2.72% 16

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Sands Capital Management's AGN Position: Q4 2013 in Review

Sands Capital Management sold out of Allergan Inc (AGN) in Q4 2013, closing a stake of 7,422,715 shares — an estimated $671M sold.

Sands Capital Management first reported a position in AGN in Q2 2013 and held it in 2 quarters. The position peaked at $809M in Q2 2013. 709 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • Sands Capital Management reported no remaining Allergan Inc position as of Q4 2013 after selling out during the quarter.
  • Sands Capital Management sold 7,422,715 Allergan Inc shares in Q4 2013, an estimated $671M.
  • Sands Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 2 quarters.
  • Sands Capital Management's Allergan Inc position peaked at $809M in Q2 2013.
  • 709 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2013.

Based on Sands Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.